Providing providers with relevant data on quality of care and profitability allows them to adjust their practices efficiently, said Erich Mounce, chief operating officer, OneOncology.
Providing providers with relevant data on quality of care and profitability allows them to adjust their practices efficiently, said Erich Mounce, chief operating officer, OneOncology.
Transcript
If a practice isn’t doing well on cost savings or achieving high-quality care, how does OneOncology approach adjusting provider practices?
Well, I think the beauty of OneOncology is it’s not this cookbook process. It’s not—here’s our only way to do it and if you don’t do it this way, we come hit you with a club. I think it’s a variation of themes. We’ve got some practices—they’re really restrict regimens. We have some practices that have a little bit more selection of preferred regimens. It’s an education process and a rapid learning cycle of how that data is recirculated back. So, the first thing we do is sort of measure where they are and then start to feedback data. Then we also show them if they would adhere a little bit more to this pathway or perform a little bit better under this contract, look how that will affect either your compensation or profitability. So, it’s really taking all of that data, and constantly feeding back accurately and allowing the doctors to buy into that. That really does tend to move physician behavior a lot more than us just saying; you guys aren’t doing well—you need to do it this way.
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
New Insights Into Meth-Associated PAH Care Gaps: Anjali Vaidya, MD, on Closing the Divide
June 4th 2025Research from Anjali Vaidya, MD, FACC, FASE, FACP, Temple University Hospital, reveals critical care gaps for patients with methamphetamine-associated pulmonary arterial hypertension (PAH), emphasizing the need for early diagnosis and integrated support.
Read More